FIELD: medicine. SUBSTANCE: method involves giving a composition prepared on the basis of prostaglandin E1 to be used as local percutaneous application to the penis. Treatment methods are also shown. EFFECT: high effectiveness of functional applications. 20 cl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR MALE SEXUAL DYSFUNCTION CORRECTION | 2008 |
|
RU2421211C2 |
| PHARMACEUTICAL COMPOSITION FOR INDUCTION OF ERECTION IN MEN (VARIANTS) | 1992 |
|
RU2098120C1 |
| PHARMACEUTICAL COMPOSITION, CONTAINING SILDENAFIL OR ALPROSTADIL, MINOXIDIL OR EUPHYLLIN, TESTOSTERON OR YOHIMBINE AND LIPOSOMES FOR LOCAL APPLICATION | 2010 |
|
RU2482847C2 |
| USE OF INHIBITORS OF CGMP-PHOSPHODIESTERASE FOR TREATMENT OF IMPOTENCY | 1996 |
|
RU2181288C2 |
| METHOD OF TREATING ERECTILE DYSFUNCTION IN PATIENTS SUFFERING RADICAL PROSTATECTOMY OR BRACHYTHERAPY | 2020 |
|
RU2741204C2 |
| METHOD OF CORRECTION OF ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS | 2001 |
|
RU2201250C2 |
| METHOD FOR TREATING ERECTILE DYSFUNCTION "JULIA" | 2015 |
|
RU2609054C1 |
| METHOD FOR ERECTILE DYSFUNCTION TREATMENT | 2016 |
|
RU2622757C1 |
| DOSAGE FORMS EFFECTIVE FOR MALE AND FEMALE SEXUAL FRUSTRATION | 2007 |
|
RU2440127C2 |
| MEDICINAL FORMULATION USEFUL IN TREATMENT OF MALE AND FEMALE IMPOTENCY | 2003 |
|
RU2313357C2 |
